Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.149 USD | 0.00% | +3.47% | -46.79% |
Kurzporträt
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Health and Wealth Supplements
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Ian Parker
CEO | Chief Executive Officer | - | - |
Michael Berg
CHM | Chairman | - | - |
John Lee
DFI | Director of Finance/CFO | - | - |
Richard Alloway
IRO | Public Communications Contact | - | 01.01.23 |
Diane Koontz
PRN | Corporate Officer/Principal | - | 26.10.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Ian Parker
CEO | Chief Executive Officer | - | - |
Director/Board Member | - | 11.01.22 | |
John Lee
DFI | Director of Finance/CFO | - | - |
Michael Berg
CHM | Chairman | - | - |
Robert McGrath
BRD | Director/Board Member | - | - |
Denver Riggleman
BRD | Director/Board Member | - | - |
Fig Annunziato
BRD | Director/Board Member | - | 14.06.22 |
Dong Yun Kim
BRD | Director/Board Member | - | 14.06.22 |
Unternehmenskontakt
% 1. Jan. | Kap. | |
---|---|---|
-46.79% | 111 Mio. | |
+6.54% | 3’004 Mrd. | |
-0.39% | 79.28 Mrd. | |
+3.76% | 77.94 Mrd. | |
-13.87% | 53.9 Mrd. | |
-19.56% | 50.22 Mrd. | |
+20.55% | 46.76 Mrd. | |
+9.19% | 39.49 Mrd. | |
+37.08% | 31.91 Mrd. | |
-13.03% | 23.99 Mrd. |
- Börse
- Aktien
- A3CNZU Aktie
- Unternehmen Healixa Inc.